David Q. Anderson

General Partner

Mark Bamforth

Operating Partner

Jared J. Bartok

General Partner

Richard A. Charpie

Founder and Managing Partner

Herbert H. Hooper

Managing General Partner

Dana L. Niles

Partner and COO

David Blair Patteson

Partner

Patrick Walsh

Operating Partner

Frank Witney

Operating Partner

73 past transactions

Sterling Medical Devices

Private Equity Round in 2022
Sterling Medical Devices is a custom electro-mechanical and software solution provider for the medical device industry.

AnaBios

Private Equity Round in 2022
AnaBios specializes in enabling human-focused drug discovery. As a CRO, AnaBios provides products and services for every stage of drug discovery. Through proprietary technology based on the use of human donor organs and tissues, it studies ex vivo human responses to drugs and further investigate the molecular and functional basis of relevant human physiology. Its research focuses primarily on the areas of high, unmet medical need, including cardiac disease and safety, pain, PKD kidney disease, and neurodegeneration. In partnership with Fortune 500 pharmaceutical companies, contract research organizations, and universities, the company's mission is to develop therapeutic advancements to help patients live longer, healthier, and more productive lives.

Vernal Biosciences

Venture Round in 2022
Vernal Biosciences specializes in high-purity mRNA for research and clinical use. Its platform processes and analytical methods will remove the guesswork and lengthy development cycles inherent to many manufacturing processes in the advanced therapeutics field. Its high-purity supply and services provide the flexibility to perform proper drug discovery and development without risking the buildout of costly teams and facilities.

Syft Technologies

Private Equity Round in 2022
Syft Technologies designs and manufactures a revolutionary Mass Spectrometer that enables detection of virtually all gaseous chemicals.

BioEcho Life Sciences

Private Equity Round in 2022
BioEcho Life Sciences develop and produce next-generation technologies and products to enable molecular biology and diagnostics laboratory workflows of higher convenience, higher robustness, and higher sustainability.

Magritek Ltd

Private Equity Round in 2021
Magritek is a producer of cryogen-free benchtop nuclear magnetic resonance spectrometers for the analytical instrument market. They provide complete NMR and MRI solutions for the fine chemical, pharmaceutical, polymer, food, and petrochemical industries, as well as components and subsystems suitable for research laboratories and chemistry education.

Arranta Bio

Series B in 2021
Arranta Bio was formed in May 2019 with the vision to be the best-in-class microbiome CDMO, developing and manufacturing live biotherapeutic products (LBPs) for pioneers targeting diseases linked to the microbiome, using bacterial fermentation, isolation, drying and encapsulation. In October 2019, we completed an $82,000,000 funding round with sole institutional investor, Ampersand Capital, company founders and colleagues, and a strategic investment from Thermo Fisher Scientific.

GeneWerk

Acquisition in 2020
GeneWerk GmbH was founded in July 2014 by Prof. Dr. Christof von Kalle, Dr. Manfred Schmidt and Dr. Annette Deichmann with participation of the German Cancer Research Center (DKFZ) Heidelberg. their team has long lasting experience in the area of integration site analysis, high throughput sequencing, whole genome sequencing and bioinformatics. It is very innovative in developing new analysis methods – perhaps also for your project?

ALPCO Diagnostics

Acquisition in 2020
American Laboratory Products offers a wide range of testing solutions, providing scientists and healthcare professionals with vital insights for advancing research and quality of care.

Arranta Bio

Venture Round in 2019
Arranta Bio was formed in May 2019 with the vision to be the best-in-class microbiome CDMO, developing and manufacturing live biotherapeutic products (LBPs) for pioneers targeting diseases linked to the microbiome, using bacterial fermentation, isolation, drying and encapsulation. In October 2019, we completed an $82,000,000 funding round with sole institutional investor, Ampersand Capital, company founders and colleagues, and a strategic investment from Thermo Fisher Scientific.

New England Peptide

Private Equity Round in 2019
New England Peptide prides itself on providing top-notch peptides and excellent customer service. We strive to constantly better ourselves and, in the process, the industry.

vivitide

Venture Round in 2019
Vivitide specializes in antibody packages and custom peptide synthesis services for small and large scale industries

N2 Biomedical LLC

Venture Round in 2019
N2 Biomedical provides coating, anodizing, and printing on medical devices such as guidewires, core wires, hypo tubes, and forming mandrels to global health care and medical device companies. It collaborates with customers, offering a comprehensive experience from concept to commercialization, as well as flexible prototype work and high-volume coating application, finishing, and printing services.

Vibalogics

Acquisition in 2019
Vibalogics is a contract development and manufacturing organization focused on complex live biological products. Vibalogics offers process development, manufacturing and fill & finish of products for biopharmaceutical companies involved in the development of oncolytic viral therapies, gene therapies, and vaccines.

Genome Diagnostics

Private Equity Round in 2019
GenDx develops and markets a comprehensive line of In Vitro Diagnostic (IVD) tests and services, analysis software and education. The company is a pioneer in the area of Sequencing-Based Typing (SBT) for transplantation offering high resolution HLA typing methods for Sanger and NGS techniques.

Canopy Biosciences

Venture Round in 2019
Canopy Biosciences is biotechnological company that provides products and services for gene editing and personalized medicine. The gene editing technology is called TUNR and targets translation elongation by inserting polyA tracks into targeted coding regions of the genome. This change then decreases the levels of mRNA transcribed from the gene and therefore suppresses protein expression. It was initially developed by Professor Sergej Djuranovic at Washington University School of Medicine and Professor Rachel Green from Johns Hopkins University. Canopy Biosciences was formed in 2016 and is headquartered in Saint Louis, Missouri.

NEOMED-LABS

Acquisition in 2018
NEOMED-LABS is a provider of clinical immunology laboratory services for biologics drug development. NEOMED-LABS is an independent, pure player in the immunology field whose team of experts and state of the art BSL2 labs were instrumental in the development, qualification, and validation of more than 30 assays supporting the FDA filing of 10 marketed vaccines whose cumulative sales is around $3bn. Our unrivaled expertise in immunotools engineering and stability testing, as well as our capacity of 200k results per year on our immunochemistry, virology, and bacteriology automated platforms are devoted to personalized services and fast track method validation.

MedPharm

Venture Round in 2018
MedPharm is the world’s leading contract provider of topical and transdermal product design and formulation development services. MedPharm are experts at reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through their unique, cost-effective, and industry-leading performance testing models. Well-established as the global leaders in dermatology, nail, mucosal membrane, and transdermal product development, MedPharm can also offer innovative solutions for ophthalmic and airway preparations recognized for their scientific rigor by regulators and investors. MedPharm has fully established Centres of Excellence in Durham, NC, USA and Guildford, Surrey, UK.

Adaptas Solutions

Private Equity Round in 2018
Adaptas Solutions is a strategic OEM supplier for key products and manufacturing service for analytical and laboratory equipment manufacturers.

Detector Technology

Private Equity Round in 2018
Detector Technology, Inc. is a world-class leading manufacturer of products and systems for OEM and equipment manufacturers. DeTech specializes in Channel Electron Multipliers, Glass Extrusion & Fabrication and Motion Control Products. With a state of the art fabrication and production facility, our dedicated team has been delivering excellence in manufacturing and customer satisfaction over the last 20 years.

LakePharma

Private Equity Round in 2017
LakePharma is a contract research organization (CRO) specializing in antibody and protein engineering, cell line development, and protein production. The company's range of services covering areas such as antibody engineering, antibody discovery, molecular engineering, protein chemistry, bioexpression, biofunction, bioprocessing and bioanalytics focus on integrated platforms to support projects throughout the drug discovery process and offers dedicated client services and sophisticated software to provide real-time access to project data via a secure cloud-based portal enabling clients to accelerate product development from lead discovery to Phase 1 clinical trials. Located in the heart of the San Francisco Bay Area, LakePharma has developed numerous in-house technology platforms to provide cost-effective and high quality services to its customers. The production processes are SOP-based and high-throughput, and have been streamlined to be exceptionally efficient on both a small and large scale. Each project is actively managed by a dedicated study director to ensure timely completion with superior results and transparent communication. Clients have real-time access to their project data and can view and receive status updates through LakePharma’s secure cloud-based Datasystems. LakePharma follows the principles of Good Laboratory Practices (GLP) to ensure the quality, reliability and integrity of study data. Upon request, services can also be performed in full compliance with FDA documentation requirements for submissions for nonclinical laboratory studies. All services are provided solely on a fee-for-service basis and are royalty-free.

Corpus Medical

Venture Round in 2017
CORPUS MEDICAL INC. provides top-notch consulting services for the medical device industry. We have extensive experience in developing a wide array of medical devices, we work fast and smart and we are passionate about what we do. From concept to market, let us be your partner.

Canopy Biosciences

Seed Round in 2017
Canopy Biosciences is biotechnological company that provides products and services for gene editing and personalized medicine. The gene editing technology is called TUNR and targets translation elongation by inserting polyA tracks into targeted coding regions of the genome. This change then decreases the levels of mRNA transcribed from the gene and therefore suppresses protein expression. It was initially developed by Professor Sergej Djuranovic at Washington University School of Medicine and Professor Rachel Green from Johns Hopkins University. Canopy Biosciences was formed in 2016 and is headquartered in Saint Louis, Missouri.

Canopy Biosciences

Seed Round in 2017
Canopy Biosciences is biotechnological company that provides products and services for gene editing and personalized medicine. The gene editing technology is called TUNR and targets translation elongation by inserting polyA tracks into targeted coding regions of the genome. This change then decreases the levels of mRNA transcribed from the gene and therefore suppresses protein expression. It was initially developed by Professor Sergej Djuranovic at Washington University School of Medicine and Professor Rachel Green from Johns Hopkins University. Canopy Biosciences was formed in 2016 and is headquartered in Saint Louis, Missouri.

Brammer Bio

Seed Round in 2016
Brammer Bio is a contract development and manufacturing organization (CDMO) serving companies seeking to develop and commercialize cell and gene therapies. With an experienced management team and exceptional scientific expertise and proven manufacturing capabilities we offer the knowledge and resources necessary to help you deliver innovative cell and gene-based therapies. Brammer Bio is focused on providing clinical and commercial supply of autologous and allogeneic cell therapies, and viral vector products for in vivo and ex vivo therapeutic applications. Along with process and analytical development and regulatory support we enable large pharma and biotech clients to accelerate the delivery of novel medicines and improve patient health. Brammer Bio occupies 45,000 ft2 of process development and phase I/II clinical manufacturing space in Alachua, FL, and is developing a 50,000 ft2 facility in Lexington, MA, with plans to build-out large-scale, phase III/commercial ready viral vector manufacturing suites, segregated cell and gene therapy suites, and QC and analytical laboratories for clinical and commercial launch services.

Avista Pharma

Seed Round in 2016
Avista Pharma Solutions is a contract testing, development and manufacturing organization encompassing over 200,000 square feet of laboratory and manufacturing space across three locations (Agawam, MA, Durham, NC, and Longmont, CO), providing pharmaceutical, animal health and medical device clients with a broad suite of scientifically-differentiated services ranging from early drug development to drug product manufacturing.

GENEWIZ

Venture Round in 2015
GENEWIZ is a leading global genomics service company. A full-service provider, GENEWIZ provides DNA sequencing, gene synthesis, molecular biology, next generation sequencing, bioinformatics, and GLP regulatory services. From the company’s founding, GENEWIZ has maintained its unwavering commitment to providing customers with the best value. Excelling in both science and customer support, GENEWIZ is dedicated to accelerating scientific discovery, as well as to developing and delivering innovative solutions for translational medicine and healthcare. Easily accessible around the world, GENEWIZ is the preferred partner at leading academic, pharmaceutical, biotechnology, agricultural, government, and clinical institutions. At GENEWIZ, it is their mission to contribute to the advancement of life sciences and technologies. Together with their clients, they can make a difference in the pursuit of scientific discoveries, better healthcare, a greener environment, and abundant food supplies. Their goal is to be the best in the world and the best for the world. Headquartered in South Plainfield, NJ, GENEWIZ is a privately-held global enterprise with locations in Boston, MA; Washington, DC Metro; Research Triangle Park, NC; San Diego, CA; Los Angeles, CA; San Francisco, CA; and Seattle, WA. International locations include Beijing, China; Suzhou, China; London, United Kingdom; Langen, Germany; and Tokyo, Japan.

Azurity Pharmaceuticals

Private Equity Round in 2015
Azurity Pharmaceuticals is a developer of drug products and technologies to address the needs of patients. Its drug products such as antimicrobial, mouthwashes, and testosterone enable pharmacists to prepare drugs for those populations who are in need of a better alternative to traditionally-compounded medications.
Elite One Source Nutritional Services, Inc. is a company that specializes in contract manufacturing for nutritional and dietary supplements. Founded in 2013 and headquartered in Missoula, Montana, the company operates as a subsidiary of DCC Health & Beauty Solutions Limited. Through its services, Elite One Source supports the production of a wide range of health-focused products, catering to the growing demand in the dietary supplement market.

NutraMed

Debt Financing in 2014
Nutramed, Inc. develops, manufactures, and markets tablet, capsule, and powder nutritional supplement products for customers in the United States and internationally. It offers a range of manufacturing services, including blending, granulation, tableting, timed release formulation, bilayer tablets, various types of tablet coatings, two-piece hard-shell encapsulation, stick-packs, multi-packs, blister cards, pack out, powder packaging, and tablet and capsule packaging. The company also offers enteric coating on tablets, capsules, and soft gels. The company was founded in 1998 and is headquartered in Chino, California

Sanova Dermatology

Seed Round in 2013
Sanova Dermatology is a cosmetic and medical dermatologist center that offers micrographic surgery, psoriasis, acne, and skin cancer treatment. Their medical services include medical dermatology, cosmetic dermatology, and skin cancer. They also involve in general dermatology, cosmetic dermatology, surgical dermatology, aesthetic laser procedures, mohs micrographic surgery, dermal fillers, botox, acne treatment, psoriasis treatment, and eczema treatment.

Bioventus

Seed Round in 2012
Bioventus is a global leader of active orthopaedic healing, providing clinically proven and cost-effective therapies and diagnostics that help patients regain active lifestyles. Bioventus' products are known for their innovation, safety and effectiveness. The company is the recognized leader in bone stimulation devices and among the leading distributors of osteoarthritis joint fluid therapies. Key products include: - EXOGEN(r) Ultrasound Bone Healing System - SUPARTZ(r) Joint Fluid Therapy (US only) - DUROLANE(r) Hyaluronic Acid, Single Injection (Outside US only) Bioventus' adherence to high quality standards, commitment to evidence-based medicine and strong ethical behavior makes the company a trusted partner for thousands of physicians worldwide. Bioventus employs 500 people and generates about $240 million in yearly revenue. The company is headquartered in Durham, N.C. Prior to launch in 2012, Bioventus was operating as the Biologics Division of Smith & Nephew.

CoreLab Partners

Venture Round in 2012
CoreLab Partners is a biotech company that provides services related to cardio health monitoring and also provides technological support.

Nitinol Devices & Components

Venture Round in 2011
NDC is a privately held medical device company headquartered in Fremont, CA, USA. Focused on the medical field, NDC provides manufacturing, research, development, regulatory and technical support on all aspects of Nitinol technology and processing, and is aggressively expanding its capabilities to meet the growing demand for its shape-memory and superelastic Nitinol products.

Blue Sky Biotech

Private Equity Round in 2011
Blue Sky Biotech, Inc. is a Contract Research Organization (CRO) in the pharmaceutical R&D market. As a trusted partner to nine of Fortune’s Top 10 Pharmaceutical Companies, Blue Sky has a proven track record with industry leaders. Blue Sky aims to alleviate the onerous and labor-intensive tasks that take scientists away from key experimentation, novel theory exploration and other optimal uses of their time. Blue Sky is synonymous with productivity in the early discovery biology processes known as genetic cloning, recombinant protein expression and laboratory-scale fermentation (scale-up bioprocessing). We are motivated by our ability to impact the overall efficiency of the drug discovery process, thus contributing to a longer, healthier lifespan for human beings.

FirstRain

Venture Round in 2010
FirstRain is a developer of a cloud-based business analytics platform used to transform the way businesses make decisions. FirstRain’s mobile, cross-platform solutions provide sales, marketing, and finance professionals analytics tuned to their specific company strategy and allow them to deeply understand their customer’s business and their markets. FirstRain’s patented, advanced analytics technology finds business-focused Web and social media and then integrates it seamlessly into the world’s premier CRM and social enterprise platforms, including Salesforce.com, Chatter, Cisco WebEx Social, Microsoft SharePoint and Dynamics, Jive, and Yammer. This intelligence is similarly incorporated into leading research platforms such as Fidelity.com, Interactive Data, and Mergent. Based in San Mateo, California, FirstRain also has offices in New York and Gurgaon, India.

Bako Diagnostics

Seed Round in 2009
Bako Integrated Physician Solutions is the premier provider of diagnostic and therapeutic services focusing on the skin, soft tissue and bone of the lower extremity. Their pathology team provides not just information, but also intelligence to enable better patient care.

Signature Genomic Laboratories

Venture Round in 2008
A Spokane, Wash.-based provider of molecular cytogenetic diagnostic services.

FirstRain

Venture Round in 2008
FirstRain is a developer of a cloud-based business analytics platform used to transform the way businesses make decisions. FirstRain’s mobile, cross-platform solutions provide sales, marketing, and finance professionals analytics tuned to their specific company strategy and allow them to deeply understand their customer’s business and their markets. FirstRain’s patented, advanced analytics technology finds business-focused Web and social media and then integrates it seamlessly into the world’s premier CRM and social enterprise platforms, including Salesforce.com, Chatter, Cisco WebEx Social, Microsoft SharePoint and Dynamics, Jive, and Yammer. This intelligence is similarly incorporated into leading research platforms such as Fidelity.com, Interactive Data, and Mergent. Based in San Mateo, California, FirstRain also has offices in New York and Gurgaon, India.

Agilux Laboratories

Seed Round in 2008
Agilux Laboratories is a contract research organization. The company offers a range of services supporting discovery, pre-clinical, and clinical services. It provides a range of drug metabolism and pharmacokinetic services for biotech and pharmaceutical industries. The company’s services include discovery bioanalytical, GLP bioanalytical, in vivo, in vitro, and Immunoassays services. It focuses on bioanalytical and PK/PD testing services for the biotech and pharmaceutical industries. Agilux Laboratories was founded by Peter Glick in 2007 and is headquartered in Worcester, Massachusetts.

RadPharm

Series B in 2007
RadPharm provides radiopharmaceutical products to medical practices in Australia. Its product portfolio includes sterile vials, cold kits, contract manufacturing, and more.

Chantest

Venture Round in 2007
ChanTest has developed the world's most complete library of validated human ion channel-expressing cell lines to serve all the ion channel needs of its pharmaceutical and biotech customers. Services range from early functional screens for profiling drug candidates or ranking within profiles during the drug-discovery process – to a complete set of in vitro GLP service products for cardiac risk assessment. ChanTest works in partnership with customers to speed the drug-development process, save time and money, and ultimately – to help make better, safer drugs.

Cequent Pharmaceuticals

Series A in 2007
An early-stage biopharmaceutical company, Cequent is pioneering the development of novel therapeutics to prevent and treat a wide range of human diseases — from inflammatory diseases to cancer — based on the company's proprietary technology, TransKingdom RNA interference (tkRNAi). Cequent's first products, now in pre-clinical development, are drug candidates targeting colon-cancer prevention and inflammatory bowel disease. The company designed its powerful tkRNAi technology to deactivate specific disease-causing genes safely and effectively, using non-pathogenic bacteria as an engine to produce and deliver RNAi directly into cells. It is based on ground-breaking scientific research originating at the Institut Pasteur (Paris, France) and at the Beth Israel Deaconess Medical Center/Harvard Medical School. A privately held company based in Cambridge, Massachusetts, Cequent was established in 2006. In July 2010, Cequent Pharmaceuticals was acquired by Marina Biotech, Inc (formerly MDRNA, Inc) for $46M.

CRI Lifetree

Seed Round in 2007
CRI Lifetree operates as a specialized research organization. The Company focuses on the conduct and design of early stage endocrinology and infectious disease research products and services. CRI Lifetree provides clinical research throughout the United States.

Magellan Diagnostics

Private Equity Round in 2006
Lead poisoning threatens millions of people, yet is entirely preventable. Our mission is to help identify and protect those at risk. Magellan Diagnostics is a medical device company that provides point-of-care systems, clinical laboratory instruments, and analytical laboratory services focused on lead testing. Headquartered outside Boston in Billerica, Massachusetts, Magellan is dedicated to offering high-quality, reliable products that help identify children and adults at risk of harm due to lead exposure. Magellan Diagnostics has been a pioneer in the analysis of blood lead since the late 1960s, when the company (then called ESA, Inc.) was founded by four PhD graduates from the Massachusetts Institute of Technology (MIT). Applying a novel technique called Anodic Stripping Voltammetry (ASV), they designed and built a bench top analyzer for the measurement of lead in blood. The company then adapted this technology to create smaller, portable instruments that can be used outside of the traditional reference laboratory. This major achievement broadened the accessibility of lead testing by bringing it to the point of care.

FirstRain

Venture Round in 2006
FirstRain is a developer of a cloud-based business analytics platform used to transform the way businesses make decisions. FirstRain’s mobile, cross-platform solutions provide sales, marketing, and finance professionals analytics tuned to their specific company strategy and allow them to deeply understand their customer’s business and their markets. FirstRain’s patented, advanced analytics technology finds business-focused Web and social media and then integrates it seamlessly into the world’s premier CRM and social enterprise platforms, including Salesforce.com, Chatter, Cisco WebEx Social, Microsoft SharePoint and Dynamics, Jive, and Yammer. This intelligence is similarly incorporated into leading research platforms such as Fidelity.com, Interactive Data, and Mergent. Based in San Mateo, California, FirstRain also has offices in New York and Gurgaon, India.

Ortho Organizers

Seed Round in 2006
Ortho Organizers, a full-line manufacturer and distributor of orthodontics products.

RadPharm

Acquisition in 2005
RadPharm provides radiopharmaceutical products to medical practices in Australia. Its product portfolio includes sterile vials, cold kits, contract manufacturing, and more.

Assay Designs

Series A in 2005
Assay Designs, founded in 1992, provides quality, rapid, and easy-to-use products for the worldwide biomedical, pharmaceutical and scientific research communities to "Simplify Your Science®". Thier rapidly expanding product line includes kits and materials for the detection and quantification of molecules that are important in cell regulation, signal transduction, inflammation, oxidative processes and apoptosis. Assay Designs develops, produces and markets CORRELATE™ and TITERZYME® immunoassay kits, detection kits, FLASHLIGHT® and BIOLIGHT™ luminescent compounds, antibodies and miscellaneous compounds. Providing unsurpassed precision and reproducibility, Assay Designs offers a broad range of eicosanoid kits and human and mouse cytokine kits and the world's only non-radioactive COX activity kit. In addition, a wide selection of related antigen and antibody products are available to meet your specific research needs. Assay Designs also offers contract manufacturing and custom design products for specialized research needs.

Medifacts International

Series A in 2005
As of February 5, 2010, Medifacts International, Inc. was acquired by CoreLab Partners. Medifacts International, Inc. provides cardiovascular safety monitoring services to the pharmaceutical and biotech industry. The company offers electrocardiogram (ECG) services, digital Holter services, ambulatory blood pressure monitoring, automated blood pressure, telemedicine, and assessment of arterial stiffness in clinical trials, as well as glucose monitoring and pulmonary services. It also provides consulting and medical writing services, including expert program and protocol design, protocol development, expert interim reports, statistical analysis plans and reports, ECG analysis, regulatory guidance and support, expert summary reports for inclusion in the clinical study reports, and statistical analysis planning and biostatistics, as well as digital data collection, transmission, and analysis. The company was founded in 1985 and is headquartered in Rockville, Maryland with additional offices in Langenfeld, Germany; and Shanghai, China.

ProGene Biomedical

Venture Round in 2004
ProGene Biomedical is a clinical reference laboratory specializing in clinical immunology and allergy testing.

Endeca

Series C in 2004
Endeca provides enterprise search for large companies including Borders, Boeing, the Census Bureau, the EPA, Ford, Hallmark, IBM, and Toshiba. The company specializes in guided search, auto-categorizing results based on the keywords someone enters. Endeca charges from $100,000 to more than $10 million per installation. Endeca competes with FAST Search & Transfer, which was [acquired](http://www.techcrunch.com/2008/01/08/microsoft-has-announced-a-takeover-bid-for-fast-search-transfer-priced-at-12-billion/) by Microsoft for 1.2 Billion in January 2008.

ESA Bioscience

Acquisition in 2004
ESA Bioscience is a company that was acquired by Ampersand Capital Partners in 2004.
Panacos Pharmaceuticals, Inc., a development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The company’s discovery technologies focus on novel targets in the virus life cycle, including virus maturation and virus fusion. Its product pipeline includes second- and third-generation programs in HIV maturation inhibition. The company was founded in 1999 and is headquartered in Watertown, Massachusetts.

Proficiency

Series D in 2004
Proficiency, Inc. provides product knowledge integration and CAD interoperability solutions that enable manufacturers and suppliers to share product knowledge from various engineering and manufacturing environments. Its solutions include product knowledge migration, which delivers a process of technology and methodology that meets migration needs; and supplier delivery solutions to original equipment manufacturers or higher tier suppliers. The company’s products also include Collaboration Gateway V7.0, which enables the transfer of the product knowledge between CAD systems that include geometry, features, sketches, manufacturing info, metadata, assembly information, and drawings in the conversion process; and Completion Wizard, which provides an interactive method of completing the process. In addition, it offers CAD translation services, such as geometry-only, product knowledge, and associative drawing translations; consulting services, such as migration strategy, supplier delivery strategy, and process integration consulting; and implementation services, such as training, customer support, and customer specific developments. The company serves various companies in the automotive, aerospace and defense, and heavy machinery industries. Proficiency, Inc. was founded in 1998 and is based in Marlborough, Massachusetts. As of July 1, 2009, Proficiency, Inc. operates as a subsidiary of ITI TranscenData.

LightPointe

Venture Round in 2004
LightPointe Communications, Inc. (a.k.a. LightPointe Wireless) is privately held. The company was launched in 1998 and is headquartered in San Diego, CA, with regional offices/presence in Europe (Germany & France) and Asia (Thailand). LightPointe also provides solutions via its AirePointe Security & Government Solutions Division (www.AirePointe.com). LightPointe is the number one manufacturer in the world of point-to-point Gigabit Ethernet Free Space Optics and Hybrid Optical-Radio Bridges, and manufactures a complete line of 4G/LTE backhaul radios (60 GHz & 70/80 GHz e-band) for telecom carriers and enterprises such as businesses, schools, the military & government agencies. With over $80 million in product development and over eight key patents, LightPointe has deployed thousands of Gigabit Ethernet bridges and digital video/security backhaul solutions worldwide.

Silicon Wave

Series F in 2003
Silicon Wave, a San Diego pioneer in the Bluetooth wireless technology.

FirstRain

Series B in 2003
FirstRain is a developer of a cloud-based business analytics platform used to transform the way businesses make decisions. FirstRain’s mobile, cross-platform solutions provide sales, marketing, and finance professionals analytics tuned to their specific company strategy and allow them to deeply understand their customer’s business and their markets. FirstRain’s patented, advanced analytics technology finds business-focused Web and social media and then integrates it seamlessly into the world’s premier CRM and social enterprise platforms, including Salesforce.com, Chatter, Cisco WebEx Social, Microsoft SharePoint and Dynamics, Jive, and Yammer. This intelligence is similarly incorporated into leading research platforms such as Fidelity.com, Interactive Data, and Mergent. Based in San Mateo, California, FirstRain also has offices in New York and Gurgaon, India.

Silicon Wave

Series E in 2003
Silicon Wave, a San Diego pioneer in the Bluetooth wireless technology.

Viadux

Venture Round in 2002
Viadux is a leading provider of in-building broadband access solutions for the telecommunications and cable industries. The company partners with service providers to deliver high-speed data, video and voice services to small-to-medium enterprises (SMEs) and residential customers in the Multi-Tenant Unit (MTU/MDU) market.

Endeca

Series C in 2002
Endeca provides enterprise search for large companies including Borders, Boeing, the Census Bureau, the EPA, Ford, Hallmark, IBM, and Toshiba. The company specializes in guided search, auto-categorizing results based on the keywords someone enters. Endeca charges from $100,000 to more than $10 million per installation. Endeca competes with FAST Search & Transfer, which was [acquired](http://www.techcrunch.com/2008/01/08/microsoft-has-announced-a-takeover-bid-for-fast-search-transfer-priced-at-12-billion/) by Microsoft for 1.2 Billion in January 2008.

Ensemble Communications

Venture Round in 2002
Ensemble Communications is a develops wireless infrastructure equipment for high-speed local broadband access applications.

Cyclis Pharmaceuticals

Series A in 2002
Cyclis is researching and developing small-molecule cancer drugs based on a novel technology designed to selectively kill cancer cells and preserve normal cells by restoring and activating cellular checkpoints known to be defective in cancers.

Endeca

Series B in 2001
Endeca provides enterprise search for large companies including Borders, Boeing, the Census Bureau, the EPA, Ford, Hallmark, IBM, and Toshiba. The company specializes in guided search, auto-categorizing results based on the keywords someone enters. Endeca charges from $100,000 to more than $10 million per installation. Endeca competes with FAST Search & Transfer, which was [acquired](http://www.techcrunch.com/2008/01/08/microsoft-has-announced-a-takeover-bid-for-fast-search-transfer-priced-at-12-billion/) by Microsoft for 1.2 Billion in January 2008.

LightPointe

Series B in 2001
LightPointe Communications, Inc. (a.k.a. LightPointe Wireless) is privately held. The company was launched in 1998 and is headquartered in San Diego, CA, with regional offices/presence in Europe (Germany & France) and Asia (Thailand). LightPointe also provides solutions via its AirePointe Security & Government Solutions Division (www.AirePointe.com). LightPointe is the number one manufacturer in the world of point-to-point Gigabit Ethernet Free Space Optics and Hybrid Optical-Radio Bridges, and manufactures a complete line of 4G/LTE backhaul radios (60 GHz & 70/80 GHz e-band) for telecom carriers and enterprises such as businesses, schools, the military & government agencies. With over $80 million in product development and over eight key patents, LightPointe has deployed thousands of Gigabit Ethernet bridges and digital video/security backhaul solutions worldwide.
Blackstone Technology Group provides software and services that create high throughput computing environments. Blackstone helps customers speed time-to-market by designing and optimizing infrastructures for high user productivity, low administrative burden, and low ownership cost. Blackstone accomplishes these goals with Consultants who have expertise in the applications and process methodologies, as well as in the design and optimization of large-scale, high-throughput computing environments; and Software products that simplify usage and administration of the environment, as well as maximize computing throughput and architecture scalability.

Silicon Wave

Series C in 2000
Silicon Wave, a San Diego pioneer in the Bluetooth wireless technology.

Silicon Wave

Series B in 1999
Silicon Wave, a San Diego pioneer in the Bluetooth wireless technology.

Silicon Wave

Series A in 1999
Silicon Wave, a San Diego pioneer in the Bluetooth wireless technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.